<p>動態科技實驗室私人有限公司在最近向證券交易委員會的披露中表示，在第二季度減少了對 Privia Health Group, Inc.（NASDAQ:PRVA - 免費報告）46.6% 的持股。該公司在出售了 23,970 股後，持有 27,426 股該公司的股票。動態科技實驗室私人有限公司在 Privia Health Group 的持股在最近的報告期末價值為 631,000 美元。</p>
<p>其他一些對沖基金和機構投資者也對該股票的持倉進行了調整。US Bancorp DE 在第一季度將其在 Privia Health Group 的持倉提高了 2.4%。US Bancorp DE 現在擁有 18,487 股該公司的股票，價值 415,000 美元，此前在上個季度增持了 429 股。蒙特利爾銀行在第二季度將其在 Privia Health Group 的持股提高了 1.9%。蒙特利爾銀行現在擁有 28,694 股該公司的股票，價值 660,000 美元，此前在上個季度增持了 543 股。CWM LLC 在第一季度將其在 Privia Health Group 的持股提高了 50.3%。CWM LLC 現在擁有 1,804 股該公司的股票，價值 40,000 美元，此前在上個季度增持了 604 股。馬里蘭州退休與養老金系統在第二季度將其在 Privia Health Group 的持股提高了 2.5%。馬里蘭州退休與養老金系統現在擁有 30,814 股該公司的股票，價值 709,000 美元，此前在上個季度增持了 763 股。最後，MQS 管理有限公司在第二季度將其在 Privia Health Group 的持倉提高了 8.5%。MQS 管理有限公司現在擁有 10,167 股該公司的股票，價值 234,000 美元，此前在此期間增持了 795 股。目前 94.48% 的股票由機構投資者和對沖基金持有。</p>
<p>獲取 <strong>Privia Health Group</strong> 的提醒：</p>
<h2>Privia Health Group 股價上漲 5.3%</h2>
<p>PRVA 的股票在週五開盤價為 23.74 美元。該公司的 50 日簡單移動平均線為 24.21 美元，200 日簡單移動平均線為 22.78 美元。Privia Health Group, Inc.的 1 年最低價為 18.77 美元，1 年最高價為 26.51 美元。該公司的市值為 29.2 億美元，市盈率為 182.63，PEG 比率為 3.95，貝塔值為 0.83。</p>
<p>Privia Health Group（NASDAQ:PRVA - 獲取免費報告）最近在 6 月 7 日（星期二）公佈了季度財報。該公司報告季度每股收益為 0.10 美元。該季度的收入為 2.1361 億美元。Privia Health Group 的淨利潤率為 0.89%，股本回報率為 2.52%。作為一個整體，研究分析師預測 Privia Health Group, Inc.在本年度將發佈 0.14 美元的每股收益。</p>
<h2>華爾街分析師觀點</h2>
<p>一些股票分析師對 PRVA 股票發表了看法。巴克萊將 Privia Health Group 的目標價從 22.00 美元上調至 23.00 美元，並在 11 月 10 日的研究報告中給予該股票 “持平” 評級。Truist Financial 在 11 月 10 日的報告中重申了 “買入” 評級，並將 Privia Health Group 的目標價設定為 31.00 美元（之前為 30.00 美元）。花旗集團在 8 月 29 日的研究報告中重申了對 Privia Health Group 的 “跑贏大盤” 評級。斯蒂芬斯在 9 月 24 日的研究報告中重申了 “增持” 評級，並對 Privia Health Group 的股票設定了 32.00 美元的目標價。最後，派珀·桑德勒在 8 月 11 日的報告中將 Privia Health Group 的目標價從 36.00 美元下調至 35.00 美元，並對該公司設定了 “增持” 評級。十三位研究分析師對該股票給予了買入評級，三位分析師給予了持有評級。根據 MarketBeat 的數據，Privia Health Group 目前的共識評級為 “適度買入”，平均目標價為 30.00 美元。</p>
<p><strong>查看我們關於 Privia Health Group 的最新股票報告</strong></p>
<h2>Privia Health Group 公司簡介</h2>
<p>（免費報告）</p>
<p>Privia Health Group, Inc.在美國作為一家國家級的醫生賦能公司運營。該公司與醫療集團、健康計劃和健康系統合作，以優化醫生實踐、提升患者體驗，並獎勵醫生在面對面和虛擬環境中提供護理。</p>
<h2>閲讀更多</h2>
<ul>
<li>我們更看好的五隻股票，勝過 Privia Health Group</li>
<li>在哪裏找到財報電話會議記錄</li>
<li>MP 材料公司在財報後股價飆升——真正原因在這裏</li>
<li>每股收益計算器：如何計算 EPS</li>
<li>為什麼 Palantir 的下滑可能是長期機會的鋪墊</li>
<li>股息貴族的最佳名單：通過貴族指數積累財富</li>
<li>收入投資者注意：這隻 REIT 正在打折出售</li>
</ul>
<p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9UFJWQQ?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9UFJWQQ"/></p>
<p><em>此即時新聞提醒由敍述科學技術和 MarketBeat 的金融數據生成，以便為讀者提供最快的報道和公正的覆蓋。請將任何問題或意見發送至 contact@marketbeat.com。</em></p>
<h2>你現在應該投資 1,000 美元在 Privia Health Group 嗎？</h2>
<p>在考慮 Privia Health Group 之前，你需要聽聽這個。</p>
<p>MarketBeat 每天跟蹤華爾街頂級評級和表現最佳的研究分析師及其推薦的股票。MarketBeat 已識別出五隻頂級分析師正在悄悄向客户推薦的股票，以便在更廣泛的市場注意到之前購買……而 Privia Health Group 並不在名單上。</p>
<p>雖然 Privia Health Group 目前在分析師中獲得了適度買入評級，但頂級分析師認為這五隻股票更值得購買。</p>
<p>查看這五隻股票</p>

PRVA

<p>動態科技實驗室私人有限公司在第二季度減少了對 Privia Health Group, Inc.的持股比例，降幅為 46.6%，目前持有 27,426 股，價值 63.1 萬美元。其他機構投資者也調整了他們的持倉。Privia Health Group 的股票上漲了 5.3%，市值為 29.2 億美元。分析師對該股票給予了 “適度買入” 的共識評級，平均目標價為 30.00 美元</p>

<p>Dynamic Technology Lab Private Ltd lessened its stake in Privia Health Group, Inc. (NASDAQ:PRVA - Free Report) by 46.6% in the 2nd quarter, according to its most recent disclosure with the Securities &amp; Exchange Commission. The firm owned 27,426 shares of the company's stock after selling 23,970 shares during the quarter. Dynamic Technology Lab Private Ltd's holdings in Privia Health Group were worth $631,000 at the end of the most recent reporting period.</p>
<div class="lb-trans"><p>動態科技實驗室私人有限公司在最近向證券交易委員會的披露中表示，在第二季度減少了對 Privia Health Group, Inc.（NASDAQ:PRVA - 免費報告）46.6% 的持股。該公司在出售了 23,970 股後，持有 27,426 股該公司的股票。動態科技實驗室私人有限公司在 Privia Health Group 的持股在最近的報告期末價值為 631,000 美元。</p>
</div><p>A number of other hedge funds and other institutional investors have also made changes to their positions in the stock. US Bancorp DE lifted its position in Privia Health Group by 2.4% in the 1st quarter. US Bancorp DE now owns 18,487 shares of the company's stock valued at $415,000 after acquiring an additional 429 shares in the last quarter. Bank of Montreal Can lifted its holdings in shares of Privia Health Group by 1.9% in the second quarter. Bank of Montreal Can now owns 28,694 shares of the company's stock valued at $660,000 after purchasing an additional 543 shares in the last quarter. CWM LLC lifted its holdings in shares of Privia Health Group by 50.3% in the first quarter. CWM LLC now owns 1,804 shares of the company's stock valued at $40,000 after purchasing an additional 604 shares in the last quarter. Maryland State Retirement &amp; Pension System lifted its holdings in shares of Privia Health Group by 2.5% in the second quarter. Maryland State Retirement &amp; Pension System now owns 30,814 shares of the company's stock valued at $709,000 after purchasing an additional 763 shares in the last quarter. Finally, MQS Management LLC boosted its position in shares of Privia Health Group by 8.5% during the second quarter. MQS Management LLC now owns 10,167 shares of the company's stock worth $234,000 after buying an additional 795 shares during the period. 94.48% of the stock is currently owned by institutional investors and hedge funds.</p>
<div class="lb-trans"><p>其他一些對沖基金和機構投資者也對該股票的持倉進行了調整。US Bancorp DE 在第一季度將其在 Privia Health Group 的持倉提高了 2.4%。US Bancorp DE 現在擁有 18,487 股該公司的股票，價值 415,000 美元，此前在上個季度增持了 429 股。蒙特利爾銀行在第二季度將其在 Privia Health Group 的持股提高了 1.9%。蒙特利爾銀行現在擁有 28,694 股該公司的股票，價值 660,000 美元，此前在上個季度增持了 543 股。CWM LLC 在第一季度將其在 Privia Health Group 的持股提高了 50.3%。CWM LLC 現在擁有 1,804 股該公司的股票，價值 40,000 美元，此前在上個季度增持了 604 股。馬里蘭州退休與養老金系統在第二季度將其在 Privia Health Group 的持股提高了 2.5%。馬里蘭州退休與養老金系統現在擁有 30,814 股該公司的股票，價值 709,000 美元，此前在上個季度增持了 763 股。最後，MQS 管理有限公司在第二季度將其在 Privia Health Group 的持倉提高了 8.5%。MQS 管理有限公司現在擁有 10,167 股該公司的股票，價值 234,000 美元，此前在此期間增持了 795 股。目前 94.48% 的股票由機構投資者和對沖基金持有。</p>
</div><p>Get <strong>Privia Health Group</strong> alerts:</p>
<div class="lb-trans"><p>獲取 <strong>Privia Health Group</strong> 的提醒：</p>
</div><h2>Privia Health Group Trading Up 5.3%</h2>
<div class="lb-trans"><h2>Privia Health Group 股價上漲 5.3%</h2>
</div><p>Shares of PRVA opened at $23.74 on Friday. The company's fifty day simple moving average is $24.21 and its 200 day simple moving average is $22.78. Privia Health Group, Inc. has a 1-year low of $18.77 and a 1-year high of $26.51. The company has a market cap of $2.92 billion, a price-to-earnings ratio of 182.63, a PEG ratio of 3.95 and a beta of 0.83.</p>
<div class="lb-trans"><p>PRVA 的股票在週五開盤價為 23.74 美元。該公司的 50 日簡單移動平均線為 24.21 美元，200 日簡單移動平均線為 22.78 美元。Privia Health Group, Inc.的 1 年最低價為 18.77 美元，1 年最高價為 26.51 美元。該公司的市值為 29.2 億美元，市盈率為 182.63，PEG 比率為 3.95，貝塔值為 0.83。</p>
</div><p>Privia Health Group (NASDAQ:PRVA - Get Free Report) last announced its quarterly earnings data on Tuesday, June 7th. The company reported $0.10 EPS for the quarter. The company had revenue of $213.61 million during the quarter. Privia Health Group had a net margin of 0.89% and a return on equity of 2.52%. As a group, research analysts forecast that Privia Health Group, Inc. will post 0.14 earnings per share for the current year.</p>
<div class="lb-trans"><p>Privia Health Group（NASDAQ:PRVA - 獲取免費報告）最近在 6 月 7 日（星期二）公佈了季度財報。該公司報告季度每股收益為 0.10 美元。該季度的收入為 2.1361 億美元。Privia Health Group 的淨利潤率為 0.89%，股本回報率為 2.52%。作為一個整體，研究分析師預測 Privia Health Group, Inc.在本年度將發佈 0.14 美元的每股收益。</p>
</div><h2>Wall Street Analyst Weigh In</h2>
<div class="lb-trans"><h2>華爾街分析師觀點</h2>
</div><p>A number of equities analysts have weighed in on PRVA shares. Barclays upped their price target on Privia Health Group from $22.00 to $23.00 and gave the stock an &#34;equal weight&#34; rating in a research report on Monday, November 10th. Truist Financial restated a &#34;buy&#34; rating and set a $31.00 target price (up previously from $30.00) on shares of Privia Health Group in a report on Monday, November 10th. Citigroup reaffirmed an &#34;outperform&#34; rating on shares of Privia Health Group in a research report on Friday, August 29th. Stephens reiterated an &#34;overweight&#34; rating and issued a $32.00 price target on shares of Privia Health Group in a research note on Wednesday, September 24th. Finally, Piper Sandler decreased their price objective on Privia Health Group from $36.00 to $35.00 and set an &#34;overweight&#34; rating for the company in a report on Monday, August 11th. Thirteen research analysts have rated the stock with a Buy rating and three have given a Hold rating to the company's stock. According to MarketBeat, Privia Health Group currently has a consensus rating of &#34;Moderate Buy&#34; and an average price target of $30.00.</p>
<div class="lb-trans"><p>一些股票分析師對 PRVA 股票發表了看法。巴克萊將 Privia Health Group 的目標價從 22.00 美元上調至 23.00 美元，並在 11 月 10 日的研究報告中給予該股票 “持平” 評級。Truist Financial 在 11 月 10 日的報告中重申了 “買入” 評級，並將 Privia Health Group 的目標價設定為 31.00 美元（之前為 30.00 美元）。花旗集團在 8 月 29 日的研究報告中重申了對 Privia Health Group 的 “跑贏大盤” 評級。斯蒂芬斯在 9 月 24 日的研究報告中重申了 “增持” 評級，並對 Privia Health Group 的股票設定了 32.00 美元的目標價。最後，派珀·桑德勒在 8 月 11 日的報告中將 Privia Health Group 的目標價從 36.00 美元下調至 35.00 美元，並對該公司設定了 “增持” 評級。十三位研究分析師對該股票給予了買入評級，三位分析師給予了持有評級。根據 MarketBeat 的數據，Privia Health Group 目前的共識評級為 “適度買入”，平均目標價為 30.00 美元。</p>
</div><p><strong>Check Out Our Latest Stock Report on Privia Health Group</strong></p>
<div class="lb-trans"><p><strong>查看我們關於 Privia Health Group 的最新股票報告</strong></p>
</div><h2>Privia Health Group Company Profile</h2>
<div class="lb-trans"><h2>Privia Health Group 公司簡介</h2>
</div><p>(Free Report)</p>
<div class="lb-trans"><p>（免費報告）</p>
</div><p>Privia Health Group, Inc operates as a national physician-enablement company in the United States. The company collaborates with medical groups, health plans, and health systems to optimize physician practices, enhance patient experiences, and reward doctors for delivering care in-person and virtual settings.</p>
<div class="lb-trans"><p>Privia Health Group, Inc.在美國作為一家國家級的醫生賦能公司運營。該公司與醫療集團、健康計劃和健康系統合作，以優化醫生實踐、提升患者體驗，並獎勵醫生在面對面和虛擬環境中提供護理。</p>
</div><h2>Read More</h2>
<div class="lb-trans"><h2>閲讀更多</h2>
</div><ul>
<li>Five stocks we like better than Privia Health Group</li>
<li>Where to Find Earnings Call Transcripts</li>
<li>MP Materials Stock Soared After Earnings—Here’s the Real Reason</li>
<li>Earnings Per Share Calculator: How to Calculate EPS</li>
<li>Why Palantir Slide May Be a Setup for a Long-Term Opportunity</li>
<li>Best of the list of Dividend Aristocrats: Build wealth with the aristocrat index</li>
<li>Attention Income Investors: This REIT Is on Sale</li>
</ul>
<div class="lb-trans"><ul>
<li>我們更看好的五隻股票，勝過 Privia Health Group</li>
<li>在哪裏找到財報電話會議記錄</li>
<li>MP 材料公司在財報後股價飆升——真正原因在這裏</li>
<li>每股收益計算器：如何計算 EPS</li>
<li>為什麼 Palantir 的下滑可能是長期機會的鋪墊</li>
<li>股息貴族的最佳名單：通過貴族指數積累財富</li>
<li>收入投資者注意：這隻 REIT 正在打折出售</li>
</ul>
</div><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9UFJWQQ" alt="" original-src="https://www.marketbeat.com/scripts/SECFilingChart.ashx?Prefix=NASDAQ&amp;Symbol=PRVA"/></p>
<p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.</em></p>
<div class="lb-trans"><p><em>此即時新聞提醒由敍述科學技術和 MarketBeat 的金融數據生成，以便為讀者提供最快的報道和公正的覆蓋。請將任何問題或意見發送至 contact@marketbeat.com。</em></p>
</div><h2>Should You Invest $1,000 in Privia Health Group Right Now?</h2>
<div class="lb-trans"><h2>你現在應該投資 1,000 美元在 Privia Health Group 嗎？</h2>
</div><p>Before you consider Privia Health Group, you'll want to hear this.</p>
<div class="lb-trans"><p>在考慮 Privia Health Group 之前，你需要聽聽這個。</p>
</div><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Privia Health Group wasn't on the list.</p>
<div class="lb-trans"><p>MarketBeat 每天跟蹤華爾街頂級評級和表現最佳的研究分析師及其推薦的股票。MarketBeat 已識別出五隻頂級分析師正在悄悄向客户推薦的股票，以便在更廣泛的市場注意到之前購買……而 Privia Health Group 並不在名單上。</p>
</div><p>While Privia Health Group currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.</p>
<div class="lb-trans"><p>雖然 Privia Health Group 目前在分析師中獲得了適度買入評級，但頂級分析師認為這五隻股票更值得購買。</p>
</div><p>View The Five Stocks Here</p>
<div class="lb-trans"><p>查看這五隻股票</p>
</div>

Dynamic Technology Lab Private Ltd 在 Privia Health Group, Inc.持有價值 631,000 美元的股票頭寸